By intervening in astrocytes, the expression, and secretion of Lcn-2, and their interactions, it is possible to effectively suppress the progression of neuroinflammation and yield positive outcomes in the treatment of neurodegenerative diseases. This evidence concerns the gene LCN2 and neurodegenerative disease.